Clinical and Translational Science Award
临床和转化科学奖
基本信息
- 批准号:9252686
- 负责人:
- 金额:$ 14.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-18 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAdoptionAreaArtsAwardBehavioralBusinessesClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesCommunity PracticeCommunity of PracticeCountryDentistryDevelopmentDiscipline of NursingDoctor of PhilosophyEducationEngineeringEnsureEnvironmentFacultyFosteringGap JunctionsGoalsHealthHealthcareHealthcare SystemsHospitalsHuman DevelopmentInstitutesInstitutionInvestmentsLearningLongevityMedicalMethodsMissionNational Research Service AwardsNew YorkNew York CityOutcomePopulation HeterogeneityRecording of previous eventsReproducibilityResearchResearch PersonnelResourcesSafetySchoolsScienceServicesSilverSocial WorkTherapeutic InterventionTimeTrainingTraining SupportTranslatingTranslational ResearchTranslationsUnited StatesUnited States National Institutes of HealthUniversitiesValidationVisionabstractingauthoritybasecare deliverycareerclinical practicecollegecommunity organizationsdesigneducation researchevidence basehealth disparityimprovedinnovationinterestmedical schoolsnext generationoperationpopulation healthprogramsskillssuccess
项目摘要
Contact PD/PI: CRONSTEIN, BRUCE Neil
OVERALL
PROJECT SUMMARY
Increasingly, the effective translation of groundbreaking biomedical discoveries and successful adoption of
evidence-based therapies and interventions aimed to improve population health and reduce health disparities
requires the coordinated efforts of multi-disciplinary and multi-sectoral partnerships with diverse expertise,
interests, and skills. The New York University (NYU)-Health and Hospitals Corporation (HHC) Clinical and
Translational Science Institute (CTSI) represents an innovative public-private research partnership designed to
foster clinical and translational research and transform the delivery of care in clinical and community practice.
With this application, we have assembled a partnership of institutions with unique and complementary
strengths: a private research university with a history of public service and substantial biomedical, behavioral,
and population health expertise (NYU), the largest municipal healthcare system in the United States (HHC), a
state psychiatric institute (Nathan Kline Institute), and various community organizations that represent the rich
diversity of populations in NYC. As the centralized hub, our CTSI catalyzes research and facilitates access to
essential core services, resources, and expertise necessary to engage in the full spectrum of clinical and
translational research across our partner institutions. Moreover, the CTSI serves as a nexus for collaboration
between investigators at our partner institutions and the nationwide network of CTSA hubs. We will build on
our success in markedly expanding clinical and translational research at our hub and an established history of
research collaboration between NYU and HHC to further accelerate the pace and impact of discovery,
development, validation, and implementation across the full spectrum of translational research. To accomplish
this goal, we propose an array of innovative and evidence-based strategies delineated in our application, all
within the framework of six overarching Specific Aims. 1) Catalyze and support innovative, collaborative
translational research that improves health across the lifespan in our diverse communities. 2) Ensure the
quality, safety, and efficiency of local clinical and translational research and to disseminate successful
approaches. 3) Stimulate, support, and disseminate innovative methods in the clinical and translational
sciences. 4) Foster community-engaged collaborative and team-based science among our diverse community
of investigators and stakeholders, rich array of partner institutions, and the national CTSA network. 5) Educate,
train, and cultivate the next generation of the translational research workforce. 6) Integrate our clinical,
education, and research missions and operations to foster a learning healthcare system.
Project Summary/Abstract Page 201
Contact PD/PI: CRONSTEIN, BRUCE Neil
OVERALL
联系PD/PI:CRONSTEIN,布鲁斯Neil
整体
项目摘要
越来越多地,突破性生物医学发现的有效翻译和成功采用
以证据为基础的治疗和干预措施,旨在改善人口健康和减少健康差距
需要具有不同专门知识的多学科和多部门伙伴关系的协调努力,
兴趣和技能。纽约大学(NYU)-健康和医院公司(HHC)临床和
转化科学研究所(CTSI)是一个创新的公私研究伙伴关系,旨在
促进临床和转化研究,并改变临床和社区实践中的护理服务。
有了这个应用程序,我们已经组装了一个独特的和互补的机构的伙伴关系,
优势:一所私立研究型大学,具有公共服务和大量生物医学,行为,
和人口健康专家(纽约大学),美国最大的市政医疗保健系统(HHC),
国家精神病研究所(内森克莱恩研究所),以及代表富人的各种社区组织
纽约市人口的多样性。作为中心枢纽,我们的CTSI促进研究并促进访问
基本的核心服务,资源和专业知识,从事全方位的临床和
我们合作机构的转化研究。此外,CTSI还作为合作的纽带
在我们的合作机构和CTSA中心的全国网络的调查员之间。我们将建立在
我们成功地在我们的中心显著扩大临床和转化研究,
纽约大学和HHC之间的研究合作,以进一步加快发现的步伐和影响,
开发,验证和实施整个范围的转化研究。完成
为了实现这一目标,我们提出了一系列创新和基于证据的战略,
在六个总体具体目标的框架内。1)促进和支持创新、协作
转化研究,在我们不同的社区改善整个生命周期的健康。2)确保
质量,安全性和当地临床和转化研究的效率,并传播成功的
接近。3)鼓励,支持和传播临床和转化领域的创新方法
以理工科为重4)在我们多元化的社区中促进社区参与的协作和团队科学
调查人员和利益相关者的参与,丰富的合作伙伴机构,以及国家CTSA网络。5)教育,
培训和培养下一代的翻译研究工作者。6)整合我们的临床,
教育,研究任务和业务,以促进学习医疗保健系统。
项目摘要/摘要第201页
联系PD/PI:CRONSTEIN,布鲁斯Neil
整体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE Neil CRONSTEIN其他文献
BRUCE Neil CRONSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE Neil CRONSTEIN', 18)}}的其他基金
Engineering Personalized Devices for Craniomaxillofacial Defects
针对颅颌面缺陷设计个性化设备
- 批准号:
10116988 - 财政年份:2019
- 资助金额:
$ 14.65万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.65万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 14.65万 - 项目类别:
Standard Grant














{{item.name}}会员




